Skip to main content

Acute Lymphoblastic Leukemia: Current Status of Therapy in Children

  • Chapter
Leukemia

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 93))

Abstract

The symptoms of acute lymphoblastic leukemia (ALL) — pallor, bleeding, and infection or erythro-, thrombo-, and granulocytopenia — are due to the massive accumulation of undifferentiated cells in the bone marrow. The purpose of therapy, therefore, is to eradicate these leukemic cells in all body compartments. Prolonged disease-free survival (and subsequent cure) depends on the rapidity and thoroughness of cytoreduction. Thus, curative efforts have evolved to their present form as aggressive combination chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andreeff M, Darzynkiewiez Z, Sharpless TK, Clarkson BD, Melamed MR (1980) Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55: 282–292

    PubMed  CAS  Google Scholar 

  2. Baumer JH, Mott MG (1978) Sex and prognosis in childhood acute lymphoblastic leukaemia. Lancet 2: 128–129

    Article  PubMed  CAS  Google Scholar 

  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galto DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British ( FAB) cooperative group. Br J Haematol 33: 451–458

    Article  PubMed  CAS  Google Scholar 

  4. Berger R, Bernheim A, Flandrin G, Daniel M-T, Schaison G, Brovet J-C, Bernard J (1979) Translocation t (8; 14) dans la leucémie lymphoblastique de type Burkitt. Nouv Presse Med 8: 181–183

    PubMed  CAS  Google Scholar 

  5. Blatt J, Poplack DG, Sherins RJ (1981) Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med 304: 1121–1124

    Article  PubMed  CAS  Google Scholar 

  6. Bleyer WA (1977) Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics. Cancer Treat Rep 61: 1419–1425

    PubMed  CAS  Google Scholar 

  7. Burchenal JH, Murphy ML (1965) Long-term survivors in acute leukemia. Cancer Res 25: 1491–1494

    PubMed  CAS  Google Scholar 

  8. Chessels JM, Hardisty RM, Rapson NT, Greaves MF (1977) Acute lymphoblastic leukaemia in children: classification and prognosis. Lancet 2: 1307–1309

    Article  Google Scholar 

  9. Ch’ien LT, Aur RJA, Stagner S, Cavallo K, Wood A, Goff J, Pitner S, Hustu HO, Seifert MJ, Simone JV (1980) Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Am Neurol 8: 273–277

    Article  Google Scholar 

  10. Creutzig U, Schellong G (1980) Rezidivbehandlung bei akuter lymphoblastischer Leukämie im Kindesalter. Langzeitremissionen nach erstem Knochenmarksrezidiv. Dtsch Med Wochenschr 105: 1109–1112

    Article  PubMed  CAS  Google Scholar 

  11. D’Angio GJ (1982) The child cured of cancer: a problem for the internist. Semin Oncol 9: 143–149

    PubMed  Google Scholar 

  12. Dinkel R, Schulze-Röbbecke T (1982) Kosten-Effektivitäs-Analyse der Zytostatikatherapie von akuter Leukämie im Kindesalter. Pharma Dialog 73

    Google Scholar 

  13. Dow LW, Borella L, Sen L, Aur RJA, George SL, Mauer AM, Simone JV (1977) Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood 50: 671–682

    PubMed  CAS  Google Scholar 

  14. Ekert H, Waters KD, Smith PJ, Ellis WM (1978) Treatment of childhood lymphocytic leukemia with high white cellcounts. Br J Cancer 38: 619–623

    Article  PubMed  CAS  Google Scholar 

  15. Eser C, Lansdown R (1977) Retrospective study of inetellectual development in children treated for acute lymphoblastic leukemia. Arch Dis Child 52: 525–529

    Article  Google Scholar 

  16. Evans AE, Gilbert E, Zandstra R (1970) The increasing incidence of central nervous system leukemia in children ( Children’s cancer study group A ). Cancer 26: 404–409

    Article  PubMed  CAS  Google Scholar 

  17. Farber S, Diamond LK, Mercer RS, Sylvester RF, Wolff JA (1978) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid ( Aminopterin ). N Eng J Med 238: 787–793

    Article  Google Scholar 

  18. Fengler R, Henze G, Langermann H-J, Brämswig J, Jobke A, Kornhuber B, Ludwig R, Ritter J, Riehm H (1982) Häufigkeit und Behandlungsergebnisse testikulärer Rezidive bei der akuten lymphoblastischen Leukämie im Kindesalter. Klin Pädiat 194: 204–208

    Article  CAS  Google Scholar 

  19. Foon KA, Herzog P, Billing RJ, Terasaki PI, Feig SA (1981) Immunologie classification of childhood acute lymphocytic leukemia. Cancer 47: 280–284

    Article  PubMed  CAS  Google Scholar 

  20. Frei E III, Holland JE, Schneiderman MA, Pinkel D, Selkirk G, Freireich EJ, Silver RT, Gold GL, Regelson W (1958) A comparative study of two regimens of combination Chemotherapie in acute leukemia. Blood 13: 1126–1148

    PubMed  Google Scholar 

  21. Gasser C (1980) Long-term survival (cures) in childhood acute leukemia. Paediatrician 9: 344–357

    PubMed  CAS  Google Scholar 

  22. George SL, Fernbach DJ, Vietti TJ, Sullivan MP, Lane DM, Haggard ME, Berry DH, Lonsdale D, Komp D (1973) Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958–1970. Cancer 32: 1542–1553

    Article  PubMed  CAS  Google Scholar 

  23. George SL, Aur RJA, Mauer SM, Simone JV (1979) A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med 300: 269–273

    Article  PubMed  CAS  Google Scholar 

  24. Green DM, Brecher ML, Blumenson LE, Grossi M, Freeman AJ (1982) The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. Cancer 50: 2722–2727

    Article  PubMed  CAS  Google Scholar 

  25. Grosch-Wörner I, Langermann H-J, Brämswig J, Henze G, Odenwald E, Ritter J, Schellong G, Riehm H (1983) Behandlungsergebnisse mit Kindern mit akuter lymphoblastischer Leukämie nach isoliertem Knochenmarksrezidiv. Klin Pädiatr 196

    Google Scholar 

  26. Haghbin M, Tan CC, Clarkson BD, Mike V, Burchenal JH, Murphy ML (1974) Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). Cancer 33: 1491–1498

    Article  PubMed  CAS  Google Scholar 

  27. Hann HWL, Lustbader ED, Evans AE, Toledano SR, Lillie PD, Jasko LB (1981) Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood. J Natl Cancer Inst 66: 285–290

    PubMed  CAS  Google Scholar 

  28. Hardisty RM, Till MM, Peto J (1981) Acute lymphoblastic leukaemia: four year survivals old and new. J Clin Pathol 34: 249–253

    Article  PubMed  CAS  Google Scholar 

  29. Henze G, Langermann H-J, Ritter J, Schellong G, Riehm H (1981) Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: a report from the BFM study group. Haematol Bluttransfus 26: 87–93 In: Neth et al. (eds) Modern trends in human leukemia 4. Springer, Berlin Heidelberg New York

    CAS  Google Scholar 

  30. Henze G, Langermann H-J, Lampert F, Neidhardt M, Riehm H (1979) Die Studie zur Behandlung der akuten lymphoblastischen Leukämie 1971-1974 der Deutschen Arbeitsge¬meinschaft für Leukämie-Forschung und -Behandlung im Kindesalter e.V.: Analyse der prognostischen Bedeutung von Initialbefunden und Therapievarianten. Klin Pädiat 191: 114–126

    CAS  Google Scholar 

  31. Henze G, Langermann H-J, Kaufmann U, Ludwig R, Schellong G, Stollmann B, Riehm H (1981) Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 3: 369–376

    PubMed  CAS  Google Scholar 

  32. Henze G, Langermann H-J, Gadner H, Schellong G, Welte K, Riehm H (1981) Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen. Klin Pädiat 193: 145–154

    Article  CAS  Google Scholar 

  33. Henze G, Langermann H-J, Fengler R, Brandeis M, Evers KG, Gadner H, Hinderfeld L, Jobke A, Kornhuber B, Lampert F, Lasson U, Ludwig R, Müller-Weihrich S, Neidhardt M, Nessler G, Niethammer D, Rister M, Ritter J, Schaaff A, Schellong G, Stollmann B, Treuner J, Wahlen W, Weinel P, Wehinger H, Riehm H (1982) Therapiestudie BFM 79/81 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: intensivierte Reinduktionstherapie für Patientengruppen mit unterschiedlichem Rezidivrisiko. Klin Pädiat 194: 195–203

    Article  CAS  Google Scholar 

  34. Hughes WT, Kuhn S, Caudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemoprophylaxis for Pneumocystis Carinii pneumonitis. N Engl J Med 297: 1419–1426

    Article  PubMed  CAS  Google Scholar 

  35. Hustu HO, Aur RJA, Verzosa MS, Simone JV, Pinkel D (1973) Prevention of central nervous system leukemia by irradiation. Cancer 32: 585–597

    Article  PubMed  CAS  Google Scholar 

  36. Hutton JJ, Coleman MS, Mofi HS, Greenwood MF, Holland P, Lampkin B, Kisker T, Krill C, Kastelic JE, Valdez L, Bollum FJ (1982) Prognostic significance of terminal transferase activity in childhood acute lymphoblastic leukemia; a prospective analysis of 164 patients. Blood 60: 1267–1276

    PubMed  CAS  Google Scholar 

  37. Jacquillat C, Weil M, Auclerc MF et al. (1978) Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patients. Cancer Chemother Pharmacol 1: 113–122

    Article  PubMed  CAS  Google Scholar 

  38. Kaneko Y, Rowley JD (1982) Clinical significance of chromosome abnormalities in childhood and adult leukemia. In: Humphrey GB et al (eds) Pankreatic tumors in children. Ni j hoff, The Hague, pp 57–78

    Chapter  Google Scholar 

  39. Lampert F (1977) Kombinations-Chemotherapie und Hirnschädelbestrahlung bei 530 Kindern mit akuter lymphoblastischer Leukämie. Dtsch Med Wochenschr 102: 917–921

    Article  PubMed  CAS  Google Scholar 

  40. Lampert F, Boosen K (1977) Morbus Hodgkin in der Remission einer akuten lymphoblastischen Leukämie. Klin Pädiat 189: 292–294

    CAS  Google Scholar 

  41. Langermann H-J, Henze G, Wulf M, Riehm H (1982) Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindesalter: prognostische Bedeutung und praktische Anwendung. Klin Pädiat 194: 209–213

    Article  CAS  Google Scholar 

  42. Lawler SD (1982) Significance of chromosome abnormalities in leukemia. Semin Hematol 19: 257–272

    PubMed  CAS  Google Scholar 

  43. Leukemia Committee and Working Party on Leukaemia in Childhood (1973) Treatment of acute lymphoblastic leukaemia. Effect of “prophylactic” therapy against central nervous system leukaemia. Br Med J 2: 381–384

    Article  Google Scholar 

  44. Mauer AM (1980) Therapy of acute lymphoblastic leukemia in childhood. Blood 56: 1–10

    PubMed  CAS  Google Scholar 

  45. Meadows AT, Massari DJ, Fergusson J, Gordon J, Littmann P, Moss K (1981) Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 2: 1015–1018

    Article  PubMed  CAS  Google Scholar 

  46. Miller DR, Leikin S, Albo V, Sather H, Hammond D (1981) Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukemia ( ALL ). Br J Haematol 48: 199–206

    PubMed  CAS  Google Scholar 

  47. Miller DR (1980) Acute lymphoblastic leukemia. Prediatr Clin North Am 27: 269–291

    CAS  Google Scholar 

  48. Miller DR, Sonley M, Karon M, Breslow N, Hammond D (1974) Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count. Cancer 34: 508–517

    Article  PubMed  CAS  Google Scholar 

  49. Moe PF, Seip M, Finne PH (1981) Intermediate dose methotrexate ( IDM) in childhood acute lymphocytic leukemia in Norway. Acta Paediatr Scand 70: 73–79

    Article  PubMed  CAS  Google Scholar 

  50. Moe PF, Lethinen M, Wegelius R, Friman S, Kreuger A, Berg A (1979) Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand 68: 301–303

    Article  PubMed  CAS  Google Scholar 

  51. Morse HG, Heideman R, Hays T, Robinson A (1982) 4;11 translocation in acute lymphoblastic leukemia: a specific syndrome. Cancer Genet Cytogenet 7: 165–172

    Google Scholar 

  52. Muriel FS, Bustelo P, Pavlovsky S, Eppinger-Helft M, Svarch E, Braier JL, Garay G, Vergara B, Birman V, Penalver J, Kvicala R, Divito J, Failace R, Dibar E (1981) Tratamiento de la leucemia linfoblastica aguda. Resultados en 1192 enfermos. Medicina (B Aires) [Suppl] 41: 5–14

    Google Scholar 

  53. Ochs JJ, Berger P, Brecher ML, Sinks LF, Kinkel W, Freeman AI (1980) Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis. Cancer 45: 2274–2278

    Article  PubMed  CAS  Google Scholar 

  54. Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, DiChiro G (1978) Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298: 815–818

    Article  PubMed  CAS  Google Scholar 

  55. Pinkel D (1971) Five year follow-up of “total therapy” of childhood lymphocytic leukemia. JAMA 216: 648–652

    Article  PubMed  CAS  Google Scholar 

  56. Pinkel D, Hernandez K, Borella L, Holton C, Aur R, Samoy G, Pratt C (1971) Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer 27: 247–256

    Article  PubMed  CAS  Google Scholar 

  57. Priest JR, Robison LL, McKenna RW, Lindquist LL, Warkentin PI, LeBien TW, Woods WG, Kersey JH, Coccia PF, Nesbit ME Jr (1980) Philadelphia chromosome positive childhood acute lymphoblastic leukemia. Blood 56: 15–22

    PubMed  CAS  Google Scholar 

  58. Prober CG, Kirk LE, Keeney RE (1982) Acyclovir therapy of chickenpox in immunosuppressed children — a collaborative study. J Pediat 101: 622–625

    Article  PubMed  CAS  Google Scholar 

  59. Riehm H, Gadner H, Henze G, Langermann H-J, Odenwald E (1980) The Berlin childhood lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol Oncol 2: 299–306

    Google Scholar 

  60. Rivera G, Aur RJA, Dahl GV, Pratt CB, Wood A, Avery TL (1980) Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia. Cancer 45: 1284–1288

    Article  PubMed  CAS  Google Scholar 

  61. Rivera G, Aur RJA, Dahl GV, Pratt CB, Hustu HO, George SL, Maurer AM (1979) Second cessation of therapy in childhood lymphocytic leukemia. Blood 53: 1114–1120

    PubMed  CAS  Google Scholar 

  62. Robison LL, Sather HN, Coccia PF, Nesbit ME, Hammond GD (1980) Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia. A report from childrens cancer study group. Am J Pediatr Hematol Oncol 2: 5–13

    Google Scholar 

  63. Rodt H, Netzel B, Thiel J, Huhn D, Haas R, Götze D, Thierfelder S (1977) Classification of leukemic cells with T- and O-ALL-specific antisera. Hematol Bluttransfus 20: 87–95

    CAS  Google Scholar 

  64. Sather H, Coccia P, Nesbit M, Level C, Hammond D (1981) Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: A report from childrens cancer study group. Cancer 48: 370–376

    Article  PubMed  CAS  Google Scholar 

  65. Sather H, Miller D, Nesbit M, Heyn R, Hammond D (1981) Differences in prognosis for boys and girls with acute lymphoblastic leukemia. Lancet 1: 739–743

    Article  PubMed  CAS  Google Scholar 

  66. Simone JV (1976) Annotation: factors that influence haematological remission duration in acute lymphocytic leukaemia. Br J Haematol 32: 465–472

    Article  PubMed  CAS  Google Scholar 

  67. Simone JV, Verzosa MS, Rudy JA (1975) Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer 36: 2099–2108

    Article  PubMed  CAS  Google Scholar 

  68. Simone JV (1982) Late complications of treatment of children with leukemia and lymphoma. In: Malignant lymphomas. Academic Press, New York, pp 663–673

    Google Scholar 

  69. Siris ES, Leventhal BG, Vaitukaitis JL (1976) Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 294: 1143–1146

    Article  PubMed  CAS  Google Scholar 

  70. Steinhorn SC, Myers MH (1981) Progress in the treatment of childhood acute leukemia: a review. Med Pediatr Oncol 9: 333–346

    Article  PubMed  CAS  Google Scholar 

  71. Thomas ED (1982) The use and potential of bone marrow allograft and whole body irradiation in the treatment of leukemia. Cancer 50: 1443–1454

    Google Scholar 

  72. Wang JJ, Freeman AI, Sinks LF (1976) Treatment of acute lymphocytic leukemia by high-dose intravenous methotexate. Cancer Res 36: 1441–1444

    PubMed  CAS  Google Scholar 

  73. Wells RJ, Mascaro K, Young PCM, Cleary RE, Baehner RL (1981) Glucocorticoid receptors in the lymphoblasts of patients with glucocorticoid-resistant childhood acute lymphocytic leukemia. Am J Pediatr Heamtol Oncol 3: 259–264

    CAS  Google Scholar 

  74. Welte K, Ebener U, Hinderfeld L, Ritter J, Henze G, Kornhuber B (1981) Die Bedeutung der Terminalen desoxynukleotidyl Transferase in der Diagnostik der akuten Leukämie des Kindes — Ergebnisse von 63 Patienten. Klin Pädiat 193–171

    Google Scholar 

  75. West RJ, Graham-Pole J, Hardisty RM, Pike MC (1972) Factors in pathogenesis of central-nervous-system leukaemia. Br Med J 2: 311–314

    Article  Google Scholar 

  76. Wolff LJ, Richardson ST, Neiburger JB, Neiburger RG, Irwin DS, Baehner RL (1976) Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers. J Pediatr 89: 956–958

    Article  PubMed  CAS  Google Scholar 

  77. Zintl F, Plenert W, Hermann J (1981) Different therapy protocols for high risk and standard risk ALL in childhood. In: Neth R, Gallo RC, Graf T, Mannweiler K, Winker K (eds) Modern trends in human leukemia 4. Springer, Berlin Heidelberg New York (Hämatologie und Bluttransfusion, vol 26 )

    Google Scholar 

  78. Zuelzer WW (1949) Current trends in hematology. Pediatrics 4: 269–276

    PubMed  CAS  Google Scholar 

  79. Zuelzer WW (1964) Implications of long-term survival in acute stem cell leukemia treated with composite cyclic therapy. Blood 24: 477–494

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Lampert, F., Henze, G., Langermann, HJ., Schellong, G., Gadner, H., Riehm, HJ. (1984). Acute Lymphoblastic Leukemia: Current Status of Therapy in Children. In: Thiel, E., Thierfelder, S. (eds) Leukemia. Recent Results in Cancer Research, vol 93. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82249-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82249-0_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82251-3

  • Online ISBN: 978-3-642-82249-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics